Cite
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials
MLA
Steven R. Alberts, et al. “Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials.” Journal of Clinical Oncology, vol. 39, Feb. 2021, pp. 642–51. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e7744308ac50d40db1ec1320a73dc22f&authtype=sso&custid=ns315887.
APA
Steven R. Alberts, Sara Lonardi, Julien Taieb, Greg Yothers, Rachel Kerr, Norman Wolmark, Takayuki Yoshino, Charles Erlichman, Thierry André, Daniel G. Haller, Alberto Zaniboni, Aimery de Gramont, Jean Francois Seitz, Carmen J. Allegra, Axel Grothey, Romain Cohen, Qian Shi, Frank A. Sinicrope, Richard M. Goldberg, … Michael J. O’Connell. (2021). Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials. Journal of Clinical Oncology, 39, 642–651.
Chicago
Steven R. Alberts, Sara Lonardi, Julien Taieb, Greg Yothers, Rachel Kerr, Norman Wolmark, Takayuki Yoshino, et al. 2021. “Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials.” Journal of Clinical Oncology 39 (February): 642–51. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e7744308ac50d40db1ec1320a73dc22f&authtype=sso&custid=ns315887.